Guillermo de Juan, Carolina Darias, Cristina Henríquez de Luna and Silvia Calzón.
The Minister of Health, Caroline Dariastoday visited the Glaxosmithkline Spain (GSK) Global Health R&D center in Tres Cantos (Madrid), where he learned first-hand regarding the company activity biopharmaceutical in research and development of medicines and vaccines once morest diseases such as malaria or tuberculosisas explained by the Ministry in a press release.
Carolina Darias has expressed her recognition towards the work that this center has been carrying out in the last 30 years in favor of world health and, especially, in the fight once morest prevalent diseases in less developed countries.
|
Cristina Henríquez and Silvia Calzón together with the Minister of Health, Carolina Darias, at the GSK facilities. |
During the visit, the Minister of Health was accompanied by the Secretary of State for Health, Silvia Calzon; the president and CEO of GSK-Spain, Cristina Henriquez; the Director of Institutional Relations, William of John; ViiV CEO, Ricardo Moreno; and the director of the GSK-Spain Global Health Unit, Javier Gamo.
Although it may contain statements, data or notes from health institutions or professionals, the information contained in Redacción Médica is edited and prepared by journalists. We recommend to the reader that any health-related questions be consulted with a health professional.
